Related Experiment Video
Updated: Aug 14, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Gene sequencing in neonates and infants with the long QT syndrome
Sung Han Shim1, Masamichi Ito, Thomas Maher
1Center for Human Genetics, Boston University School of Medicine, MA 02118, USA.
Insights
Genetic analysis of infants with Long QT Syndrome (LQTS) revealed multiple mutations, including novel ones, in key genes. Compound heterozygotes or digenic inheritance cases showed more severe LQTS, emphasizing early diagnosis and treatment.
Area of Science:
- Genetics
- Pediatrics
- Cardiology
Background:
- Autosomal dominant Long QT Syndrome (LQTS) poses a significant risk of life-threatening ventricular arrhythmias in infants and neonates.
- Early identification and molecular diagnosis are crucial for managing LQTS and preventing sudden cardiac events.
Purpose of the Study:
- To investigate the clinical and molecular characteristics of LQTS in a cohort of neonates and infants.
- To identify mutations in LQTS-associated genes and correlate them with disease severity.
Main Methods:
- DNA extraction and mutation analysis of 18 exons across 5 key LQTS genes (KCNQ1, HERG, SCN5A, KCNE1, KCNE2) in 7 infant patients.
- Analysis of mutation types, including single mutations, compound heterozygosity, and digenic inheritance.
Main Results:
- Eleven mutations were identified in the 7 patients, with 4 novel mutations discovered.
- Four patients exhibited compound heterozygosity or digenic inheritance; three had single mutations.
- Mutations were predominantly found in the HERG and SCN5A genes, with one mutation in KCNE1.
Conclusions:
- Genetic complexity, such as compound heterozygosity or digenic inheritance, may be associated with more severe LQTS phenotypes, including early-onset manifestations in neonates and infants.
- Prompt molecular diagnosis and consideration of interventions like pacemaker implantation are vital for managing LQTS.
Abstract:
The objective was to analyze the clinical and molecular findings in a cohort of neonates and infants with the autosomal dominant long QT syndrome (LQTS). Those affected face a high risk of ventricular arrhythmia resulting in syncope, seizure or sudden death. Blood samples submitted for molecular diagnostic studies on 7 infants were subject to DNA extraction and mutation analysis of 18 selected exons in 5 LQTS genes (KCNQ1, HERG, SCN5A, KCNE1, and KCNE2). We detected 11 mutations in these 7 patients. Four patients had 2 mutations in 1 gene (compound heterozygotes) or 2 different genes (digenic inheritance), while 3 patients had 1 mutation each. Except for 1 mutation in KCNE1, all other mutations were detected alone or in combination within HERG and the SCN5A genes. Four of the mutations we found are novel. The lethal nature of the LQTS demands careful attention to the family history and prompt and precise diagnosis and treatment with serious consideration of endocardial pacemaker implantation. While much larger studies are needed, our data suggest that compound heterozygotes or those with 2 mutations in different genes are likely to have a more severe LQTS including early manifestations in neonates and infants.
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...
Sanger Sequencing
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

